# Psilocybin-Assisted Group Integration Psychotherapy for Treatment-Resistant Depression

> **NCT07737990** · NA · ENROLLING_BY_INVITATION · sponsor: **Joshua Rosenblat** · enrollment: 65 (estimated)

## Conditions studied

- Treatment-resistant Depression (TRD)

## Interventions

- **OTHER:** Group integration therapy

## Key facts

- **NCT ID:** NCT07737990
- **Lead sponsor:** Joshua Rosenblat
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2026-07-01
- **Primary completion:** 2029-12-31
- **Final completion:** 2030-06-30
- **Target enrollment:** 65 (ESTIMATED)
- **Last updated:** 2026-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07737990

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07737990, "Psilocybin-Assisted Group Integration Psychotherapy for Treatment-Resistant Depression". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07737990. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*